Discontinuation report FOSRENOL
Report ID | 228178 |
Drug Identification Number | 02287153 |
Brand name | FOSRENOL |
Common or Proper name | Lanthanum carbonate hydrate chewable tablets |
Company Name | TAKEDA CANADA INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | LANTHANUM |
Strength(s) | 500MG |
Dosage form(s) | TABLET (CHEWABLE) |
Route of administration | ORAL ORAL |
Packaging size | 2 Bottles of 45 tablets |
ATC code | V03AE |
ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2024-07-31 |
Actual discontinuation date | 2024-06-10 |
Remaining supply date | 2024-06-10 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | Remaining lot expires SEP2025 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 22 ADELAIDE STREET WEST TORONTO, ONTARIO CANADA M5H 4E3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2024-06-10 | French | Compare |
v3 | 2024-06-10 | English | Compare |
v2 | 2024-05-16 | French | Compare |
v1 | 2024-05-16 | English | Compare |
Showing 1 to 4 of 4